Back
Catalyst Pharmaceuticals Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
$21.62
Seasonality Move:
14.26%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here-
The current trend is relatively stagnant and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.55 | Buy |
| 20-day SMA: | 21.79 | Sell |
| 50-day SMA: | 21.77 | Sell |
| 200-day SMA: | 18.31 | Buy |
| 8-day EMA: | 21.58 | Buy |
| 20-day EMA: | 21.67 | Sell |
| 50-day EMA: | 21.44 | Buy |
| 200-day EMA: | 18.92 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 49.44 | Sell |
| Chaikin Money Flow: | 213228 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.32 - 22.06) | Sell |
| Bollinger Bands (100): | (19.31 - 22.15) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.62 while CPRX 8-day simple moving average is 21.55, which is a Buy signal.
-
The stock price of CPRX is 21.62 while Catalyst Pharmaceuticals 20-day SMA is 21.79, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day simple moving average is 21.77 while CPRX share price is 21.62, making it a Sell technically.
-
CPRX stock price is 21.62 and Catalyst Pharmaceuticals 200-day simple moving average is 18.31, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a BuyThe current Catalyst Pharmaceuticals [CPRX] share price is $21.62. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.6B
Price in USD:
21.62
Share Volume:
247.3K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
24.27
52-Week Low:
13.12
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?The Catalyst Pharmaceuticals stock price is 21.62 USD today.
-
Will CPRX stock go up or go down?Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Catalyst Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
-
Catalyst Pharmaceuticals share price is 21.62 while CPRX 8-day exponential moving average is 21.58, which is a Buy signal.
-
The stock price of CPRX is 21.62 while Catalyst Pharmaceuticals 20-day EMA is 21.67, which makes it a Sell.
-
Catalyst Pharmaceuticals 50-day exponential moving average is 21.44 while CPRX share price is 21.62, making it a Buy technically.
-
CPRX stock price is 21.62 and Catalyst Pharmaceuticals 200-day simple moving average is 18.92, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.05 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
-
CPRX Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Catalyst Pharmaceuticals is a Sell
-
Catalyst Pharmaceuticals Relative Strength Index (RSI) is 49.44, which suggest Catalyst Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Catalyst Pharmaceuticals is (21.32 - 22.06), which suggest Catalyst Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Catalyst Pharmaceuticals is (19.31 - 22.15), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.